The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

 
Web www.patentalert.com

< Polyol fatty acid polyesters process and polyurethanes therefrom

< Methods for the preparation of polyol esters that are light in color

> Methods of identifying agents for inhibiting lentivirus replication

> RRP sequences and knockout mice and uses thereof
~ 00218